Mark J. Rosenblum
2023 - Flex Pharma
In 2023, Mark J. Rosenblum earned a total compensation of $355.8K as Executive Vice President, Finance and Chief Financial Officer at Flex Pharma, a 28% decrease compared to previous year.
Compensation breakdown
| Salary | $330,000 |
|---|---|
| Stock Awards | $12,560 |
| Other | $13,200 |
| Total | $355,760 |
Rosenblum received $330K in salary, accounting for 93% of the total pay in 2023.
Rosenblum also received $12.6K in stock awards and $13.2K in other compensation.
Rankings
In 2023, Mark J. Rosenblum's compensation ranked 2,371st out of 2,978 executives tracked by ExecPay. In other words, Rosenblum earned more than 20.4% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 2,371 out of 2,978 | 20th |
Division Manufacturing | 1,333 out of 1,637 | 19th |
Major group Chemicals And Allied Products | 781 out of 906 | 14th |
Industry group Drugs | 762 out of 869 | 12th |
Industry Pharmaceutical Preparations | 548 out of 627 | 13th |
Source: SEC filing on November 1, 2024.
Rosenblum's colleagues
We found one more compensation record of an executive who worked with Mark J. Rosenblum at Flex Pharma in 2023.
2023
David and
Flex Pharma